What is BEYOND?

Category: Others


BEYOND study looks at whether increasing the dose of Betaseron to 500 mcg might result in fewer relapses for previously untreated MS patients. The study compared the effectiveness and tolerability of Betaseron 500 mcg with Betaseron 250 mcg, and Copaxone® 20 mg, a non-interferon MS therapy.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 1
None 0

Commonly reported side effects and conditions associated with BEYOND

Side effect Patients

Why patients stopped taking BEYOND

Multiple reasons could be selected

Reason Patients
Course of treatment ended 1
See 1 patient who's stopped using BEYOND


Stopped using BEYOND

Duration Patients
2 - 5 years 1
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 0
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 0
Last updated:
There are no evaluations for BEYOND.